Novo Nordisk A/S (NYSE: NVO) is a global leader in diabetes care and chronic disease treatment, based in Denmark. The company is widely recognized for its breakthrough GLP-1 therapies such as Ozempic and Wegovy, used for diabetes and weight management. Traded under the symbol NVO, it operates in the healthcare sector and is a top stock for investors tracking innovation in metabolic and endocrine therapies.
Get started in minutes! open your Evest Trading Account and invest in NVO today:
Create Your Trading Account :
Sign up for a free trading account and complete identity verification
Add Funds :
Deposit money using your preferred payment method - fast and secure
Trade NOVO :
Set the number of lots to buy or sell and confirm your order with a single click